Cleared Traditional

K791792 - SCI MED PERICARDIAL SUBSTITUTE

K791792 is the FDA 510(k) clearance for SCI MED PERICARDIAL SUBSTITUTE by Scimed Life Systems, Inc.. It is a Class 2 Cardiovascular device (product code DXZ) cleared through the Traditional 510(k) pathway after a 85-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1979
Decision
85d
Days
Class 2
Risk

K791792 is an FDA 510(k) clearance for the SCI MED PERICARDIAL SUBSTITUTE. Classified as Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene (product code DXZ), Class II - Special Controls.

Submitted by Scimed Life Systems, Inc. (Mchenry, US). The FDA issued a Cleared decision on December 7, 1979 after a review of 85 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.3470 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Scimed Life Systems, Inc. devices

Submission Details

510(k) Number K791792 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 13, 1979
Decision Date December 07, 1979
Days to Decision 85 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 125d · This submission: 85d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXZ Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.3470
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXZ Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene

All 35
Devices cleared under the same product code (DXZ) and FDA review panel - the closest regulatory comparables to K791792.
DACRON PLEDGET SUTURE BUTTRESS
K812254 · Ethicon, Inc. · Aug 1981
TEFLON PLEDGET SUTURE BUTTRESS
K811872 · Ethicon, Inc. · Aug 1981
IONESCU-SHILEY PERICARDIAL PATCH
K801764 · Shiley, Inc. · Aug 1980
FELT, SURGICAL DACRON
K760516 · Meadox Medicals, Div. Boston Scientific Corp. · Jan 1977